VBI Vaccines, Inc. - Ordinary Shares (NQ:VBIV)

0.0653 UNCHANGED

Last Price Updated: 4:00 PM EDT, Aug 7, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about VBI Vaccines, Inc. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >

40 Stocks Moving In Thursday's Mid-Day Session ↗

December 02, 2021

Gainers Biofrontera Inc. (NASDAQ: BFRI) surged 39% to $6.02. Biofrontera announced Notice of Allowance for U.S. patent titled 'Illumination for Photodynamic Therapy.'...

Via Benzinga

Topics Intellectual Property

27 Stocks Moving in Thursday's Pre-Market Session ↗

December 02, 2021

Gainers Phunware, Inc. (NASDAQ: PHUN) rose 25.8% to $4.09 in pre-market trading after surging around 12% on Wednesday. Digital World Acquisition Corp. (NASDAQ: DWAC)...

Via Benzinga

VBI Vaccines Reveals Updated Overall Survival Data From Brain Cancer Vaccine Trial ↗

December 02, 2021

VBI Vaccines Inc (NASDAQ: VBIV) has presented updated 12-month and 18-month overall survival (OS) data from the Phase 2a study of VBI-1901, the Company's...

Via Benzinga

VBI Vaccines to Present New Overall Survival Data from Phase 2a Study in Recurrent GBM at the World Vaccine & Immunotherapy Congress 2021

December 01, 2021

From VBI Vaccines Inc.

Via Business Wire

BYSI Stock Alert: Bad News From the FDA Has BeyondSpring Tanking Today ↗

December 01, 2021

BeyondSpring is falling hard after the FDA turned down a once-promising drug candidate. Here's why you shouldn't write off BYSI stock.

Via InvestorPlace

Nubank IPO: 12 Things for Potential Investors to Know About the Buffett-Backed Brazilian Fintech ↗

December 01, 2021

Nubank is in the news today as investors discuss new details from the fintech company's filing for an initial public offering (IPO).

Via InvestorPlace

Topics Initial Public Offering

OP Stock: 13 Things for OceanPal Investors to Know About the Diana Shipping Spinoff as Shares Soar ↗

December 01, 2021

OceanPal (OP) stock is riding higher Wednesday on the wave of its public debut yesterday after a spinoff from Diana Shipping (DSX)!

Via InvestorPlace

VBIV Stock Is Shooting Higher on Big FDA Vaccine Approval News ↗

December 01, 2021

VBI Vaccines just got the green light from the FDA for its new Hepatitis B vaccine. VBIV stock is reacting well so far today.

Via InvestorPlace

FDA Approves VBI Vaccines' 3-Antigen Hepatitis B Vaccine ↗

December 01, 2021

The FDA has approved VBI Vaccines Inc's (NASDAQ: VBIV) PreHevbrio [Hepatitis B Vaccine (Recombinant)] to prevent the infection caused by all known subtypes of...

Via Benzinga

VBI Vaccines Announces FDA Approval of PreHevbrio™ for the Prevention of Hepatitis B in Adults

December 01, 2021

From VBI Vaccines Inc.

Via Business Wire

The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout ↗

November 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Cumberland Gets FDA Approval For IV-Delivered Ibuprofen For Use In Pre-...

Via Benzinga

The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, & More ↗

November 28, 2021

Biotech stocks advanced in the week ending Nov. 26, as a late-week surge on the back of news about a new COVID-19 variant helped mitigate the losses notched earlier in the holiday-shortened week.

Via Talk Markets

The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, BeyondSpring, CTI Biopharma And Merck Take The Spotlight In A Light Calendar Week ↗

November 28, 2021

Biotech stocks advanced in the week ending Nov. 26, as a late-week surge on the back of news about a new COVID-19 variant, named Omicron, helped mitigate the losses...

Via Benzinga

VBI Vaccines to Participate in Jefferies London Healthcare Conference

November 16, 2021

From VBI Vaccines Inc.

Via Business Wire

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗

November 08, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...

Via Benzinga

VBI Vaccines Announces Third Quarter 2021 Financial Results and Provides Corporate Update

November 08, 2021

From VBI Vaccines Inc.

Via Business Wire

Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates ↗

November 02, 2021

The loaded Prescription Drug User Fee Act (PDUFA) calendar for October produced mixed outcomes. PDUFA dates are key binary events for biotech stocks that can move the needle in a...

Via Benzinga

VBI Vaccines Announces e-Poster Presentation of 3-Antigen Prophylactic Hepatitis B Vaccine Data at The Liver Meeting® 2021

November 01, 2021

From VBI Vaccines Inc.

Via Business Wire

VBI Vaccines Announces Publication of Results from Pivotal Phase 3 Study, CONSTANT, of VBI’s Prophylactic 3-Antigen Hepatitis B Vaccine Candidate in The Journal of the American Medical Association Network Open

October 13, 2021

From VBI Vaccines Inc.

Via Business Wire

VBI Vaccines to Participate in Upcoming Investor Conferences

October 04, 2021

From VBI Vaccines Inc.

Via Business Wire

VBI Vaccines Announces New Preclinical Data and Initiation of VBI-2905 Clinical Study Targeting Broadened Immunity Against COVID-19 and Variants of Concern

September 29, 2021

From VBI Vaccines Inc.

Via Business Wire

VBI Vaccines Announces Second Quarter 2021 Financial Results and Provides Corporate Update

August 02, 2021

From VBI Vaccines Inc.

Via Business Wire

VBI Vaccines Appoints Linda Bain to Board of Directors

July 07, 2021

From VBI Vaccines Inc.

Via Business Wire

VBI Vaccines Reports New CPT Code Issued for a 3-Antigen Prophylactic Hepatitis B Vaccine

July 01, 2021

From VBI Vaccines Inc.

Via Business Wire

Why Shares of VBI Vaccines Soared, and Then Fell 7%, on Tuesday ↗

June 29, 2021

Investors almost seemed ready to take profits once shares hit their highest level since February.

Via The Motley Fool

VBI Vaccines Stock Is Trading Higher On Encouraging Data From COVID-19 Vaccine Candidate Trial ↗

June 29, 2021

VBI Vaccines Inc (NASDAQ: VBIV) has announced positive Phase 1 data from its Phase 1/2 trial evaluating its enveloped virus-like particle (eVLP) COVID-19 vaccine...

Via Benzinga

VBI Vaccines Announces Initial Positive Phase 1 Data for Its eVLP Vaccine Candidate Against COVID-19

June 29, 2021

From VBI Vaccines Inc.

Via Business Wire

Brii Biosciences and VBI Vaccines Present Positive Data from Completed Phase 1b/2a Study on BRII-179 (VBI-2601) in Patients with Chronic Hepatitis B at the International Liver Congress 2021

June 23, 2021

From Brii Biosciences

Via Business Wire

VBI Vaccines to Present at Upcoming Scientific Conferences

June 17, 2021

From VBI Vaccines Inc.

Via Business Wire

VBI Vaccines Announces Results of Annual General Meeting

June 09, 2021

From VBI Vaccines Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.